http://www.imim.cat/noticies Programa de recerca: Neuropsicofarmacologia http://www.imim.cat/noticies/view.php?ID=876 <p>Alzheimer&#39;s research has reached a pivotal moment. Advances made in recent years point towards a new era in the diagnosis and treatment of the disease, one of the leading causes of dementia worldwide, affecting more than 800,000 people in Spain alone. To examine where we are now and where the field is heading, <em>The Lancet</em> has published an in-depth <em>Seminar</em> article aimed at medical students and healthcare professionals who are not specialists in this area.</p> <p>Among the seven international experts selected to prepare the article is Dr Marc Suárez-Calvet, from the Barcelona Brain Health Center (BBHC) at Hospital del Mar, the Hospital del Mar Research Institute and the Barcelona&beta;eta Brain Research Center of the Pasqual Maragall Foundation. Below, he outlines the main conclusions.</p> 21/09/2026